Logo

American Heart Association

  33
  0


Final ID:

Mortality or bust: what makes for a meaningful VT trial outcome?

  • Stevenson, William  ( Vanderbilt University Medical Ctr , Nashville , Tennessee , United States )
  • Gerstenfeld, Edward  ( UCSF , SanFrancisco , California , United States )
  • Author Disclosures:
    William Stevenson: DO have relevant financial relationships ; Other (please indicate in the box next to the company name):abbott speaking honoria:Active (exists now) ; Researcher:Adagio:Active (exists now) ; Other (please indicate in the box next to the company name):Mediasphere- speaking honoria:Active (exists now) ; Other (please indicate in the box next to the company name):Biotronik speaking honoria:Past (completed) ; Other (please indicate in the box next to the company name):Boston Scientific - speaking honoria:Active (exists now) ; Other (please indicate in the box next to the company name):JOhnson and Johnson - speaking honoria:Active (exists now) | Edward GERSTENFELD: DO have relevant financial relationships ; Research Funding (PI or named investigator):Abbott:Past (completed) ; Consultant:Adagio Medical:Past (completed) ; Consultant:Medtronic:Active (exists now) ; Consultant:Biosense-Webster:Active (exists now) ; Consultant:Boston Scientific:Active (exists now) ; Consultant:Abbott:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Defining Success in EP Clinical Trials

Friday, 11/07/2025 , 09:45AM - 11:00AM

Cardiovascular Seminar

More abstracts from these authors:
Needle Ablation in LV Summit VT

Tedrow Usha, Stevenson William

Pulsed Field Ablation for AT near the Phrenic nerve

Gerstenfeld Edward, Koruth Jacob

You have to be authorized to contact abstract author. Please, Login
Not Available